CTSOVSSLXN• 28 Days (Normalized)
CTSO vs SLXN (Cytosorbents Corporation vs Silexion Therapeutics Corp)
Showing Closing Date Range from Sep 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+1178.65%
Cytosorbents Corporation
Normalized Baseline0.00%
SLXN Performance $0.32
-10.26%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+1188.91 pts
CTSO outperforming by 1188.91 percentage points
CTSOSLXN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(15 dates)
| Date | CTSO Price | CTSO Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $4.91 | +1178.65% | $0.32 | -10.26% | +1188.91% |
| Sep 22, 2026 | $- | $0.39 | +11.68% | - | |
| Sep 21, 2026 | $5.51 | +1334.90% | $0.54 | +54.99% | +1279.91% |
| Sep 18, 2026 | $5.75 | +1397.40% | $0.44 | +24.22% | +1373.18% |
| Sep 17, 2026 | $5.76 | +1400.00% | $0.38 | +8.26% | +1391.74% |
| Sep 16, 2026 | $5.73 | +1392.19% | $0.34 | -3.13% | +1395.32% |
| Sep 15, 2026 | $6.06 | +1478.12% | $0.34 | -3.13% | +1481.25% |
| Sep 14, 2026 | $6.07 | +1480.73% | $0.39 | +9.80% | +1470.93% |
| Sep 11, 2026 | $6.41 | +1569.27% | $0.36 | +1.71% | +1567.56% |
| Sep 10, 2026 | $6.37 | +1558.85% | $0.42 | +20.51% | +1538.34% |
| Sep 09, 2026 | $6.33 | +1548.44% | $0.35 | -0.28% | +1548.72% |
| Sep 08, 2026 | $- | $0.35 | -1.71% | - | |
| Sep 04, 2026 | $0.35 | -8.85% | $0.35 | +0.28% | -9.13% |
| Sep 03, 2026 | $0.35 | -8.85% | $0.35 | +0.28% | -9.13% |
| Sep 02, 2026 | $0.38 | +0.00% | $0.35 | +0.00% | +0.00% |